Bangladesh Registration Transfer: The Three Required Documents

1. Key takeaways

To transfer the registration of a device in Bangladesh, three documents must be available at the same time: ① the original registration certificate held by the current registration holder; ② the No Objection Letter (NOL) issued by that holder; and ③ the transfer authorisation issued by the manufacturer. If any one of the three is missing, the transfer stalls. If the licence holder refuses to release the original, the manufacturer’s only remaining remedy is litigation — and that is a long path and a last resort.

• Transfer requires three documents: the original license from the current registration holder, a No Objection Letter from them, and an authorisation from the manufacturer (practical estimate, interviewed practitioner).
• How commonly the original is withheld: “It is very common. Even global giant manufacturers have faced this problem” (practical estimate).
• Remedy: only litigation remains, and it is a long path and a last resort (practical estimate).
• Duplicate certificate fee: practical figures of BDT 500 + 75 (pending verification) (practical estimate, pending verification).
• Obligated parties: §4.6 and §5 of the Guidelines hang the obligations on “the manufacturer or the importer” (provisions of the DGDA Medical Device Registration Guidelines).

2. Legal basis

The table below consolidates the basis for the transfer requirement. The three-document set, the prevalence of withheld originals and the litigation-only remedy all rest on statements from an interviewed practitioner, classified as a practical estimate. The duplicate certificate fee figure is explicitly marked pending verification. The allocation of obligations under the Guidelines is cited from §4.6 and §5 of the DGDA Medical Device Registration Guidelines, which frame the regulatory context in which the transfer operates.

3. Expert insights

Insight one: the hardest of the three documents to obtain is the one held by someone else. The manufacturer’s transfer authorisation is issued by the manufacturer itself; the no objection letter and the original certificate both depend on the cooperation of the licence holder. This means the initiative in a transfer does not sit with the manufacturer, unless the return obligation has been locked into the agreement in advance. The asymmetry is structural: the document the manufacturer controls is the one that was never going to be withheld, while the two documents that actually gate the transfer live in another party’s filing cabinet and are released only when that party sees advantage in releasing them.

Insight two: this risk is amplified to its maximum when the licence holder is also the distributor. A distributor facing replacement has the strongest motive to withhold, and it is precisely the party holding the original certificate and the ability to issue the NOL. The scenario described by the interviewed practitioner is exactly this: the licensed distributor stops importing but does not hand over the certificate, and the manufacturer’s business comes to a standstill. The dual role concentrates both the commercial conflict and the regulatory control in the same hands, which is why the structural fix must be applied at the point of signing rather than at the point of dispute.

Insight three: an independent licence holder is the institutional hedge against this structural risk. Having an entity that does no distribution hold the licence, and agreeing in the contract that the certificate is returned “within 72 hours of receiving confirmation”, reduces the exit cost from the litigation level to the process level. This is a problem that structural design can solve; it should not be left to litigation. The marginal cost of negotiating the clause at signing is close to zero, while the marginal cost of enforcing it after a relationship breakdown is measured in years of stalled business and legal spend.

4. Practical recommendations

• Discuss the “exit clauses” with the client before cooperation begins — in our view this matters more than negotiating the “entry clauses”.
• Require the local licence holder partner to commit in writing to returning the original registration certificate and issuing the NOL within 72 hours of receiving the manufacturer’s written confirmation.
• Put this commitment in the body of the agreement, not only in an annex or a verbal assurance.
• For clients already trapped in a transfer deadlock: first fix the evidence (confirm the DAR number, the certificate status, and the historical NOC correspondence), then engage Bangladesh local counsel to assess the feasibility of litigation, and simultaneously pursue “registering a new product line” as an alternative path.
• Pre-prepare the template of the manufacturer’s transfer authorisation and reserve the signatory, so the document the manufacturer controls is never the bottleneck.
• Confirm before signing that the licence holder and the distributor are not the same entity.

5. Verification checklist

• □ The agreement sets a deadline for the licence holder to return the original registration certificate (recommended ≤72 hours)
• □ The agreement sets the deadline and conditions for the licence holder to issue the NOL
• □ The template of the manufacturer’s transfer authorisation has been pre-prepared and the signatory reserved
• □ It has been confirmed that the licence holder and the distributor are not the same entity
• □ Re-registration has been reserved as the fallback path if the transfer fails
• □ The duplicate certificate fee (BDT 500 + 75) has been marked as pending verification

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Bangladesh. Our team prepares dossiers to DGDA expectations, manages submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Regulatory information verified as of October 27, 2026.